November 15, 2022
An investigational dihydroergotamine nasal spray for the acute treatment of migraine failed to meet its co-primary endpoints in a late-stage study, according to topline results announced […]
November 15, 2022
What should you do if a patient with multiple sclerosis suffers an acute relapse, but the standard methylprednisolone treatment does not result in any improvement? As […]
November 14, 2022
The investigational anti-amyloid monoclonal antibody gantenerumab (Genentech/Roche) showed no clear benefit for patients with early Alzheimer’s disease (AD) in the phase 3 GRADUATE I and II […]
November 11, 2022
Of the more than 6 million Alzheimer’s patients in the U.S. age 65 or older, nearly two-thirds are women. A new study may help explain the gender gap — […]
November 11, 2022
Among older adults who use the US Supplemental Nutrition Assistance Program (SNAP), rates of memory decline appear to be slower than among those who don’t use […]
November 9, 2022
Anti-tumor necrosis factor alpha (TNF-alpha) inhibitors are associated with an increased risk for multiple sclerosis (MS), especially among patients with rheumatic disease (RD), new research shows. […]
November 8, 2022
In two retrospective studies that drew from the international MSBase registry, autologous hematopoietic stem cell therapy (AHSCT) did not outperform a disease-modifying therapy (DMT) in patients […]
November 8, 2022
Early weight loss after a diagnosis of Parkinson’s disease (PD) may be a harbinger of more rapid deterioration in cognitive function, new research suggests. Results showed […]
November 8, 2022
Epstein-Barr Virus (EBV) is a suspect in the development of multiple sclerosis (MS), and recent research developments have strengthened that connection. In 2022, two studies received […]